Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand

被引:40
作者
Colli, E [1 ]
Tong, D
Penhallegon, R
Parazzini, F
机构
[1] Pharmacia & Upjohn Inc, Global Med Affairs, Bridgewater, NJ 08808 USA
[2] Pharmacia & Upjohn Inc, Res & Dev, Kalamazoo, MI 49001 USA
[3] Univ Milan, Prima Clin Ostetr Ginecol, Milan, Italy
关键词
contraceptive methods; discontinuation; intermenstrual bleeding;
D O I
10.1016/S0010-7824(99)00027-X
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
To estimate the frequency and the medical and nonmedical reasons for discontinuation of oral contraceptive (OC), intrauterine device (IUD), and injectable depot medroxyprogesterone acetate (DMPA) use, data from a cohort of experienced contraceptive users in New Zealand are re ported. The current analysis consists of 2469 OC, 2072 IUD, and 1721 DMPA users followed over a period of 5 years. The percentage of women who discontinued the use of the method within 24 months after entry into the cohort were 42%, 44%, and 48%, respectively, for OC, IUD, and DMPA: these differences were not statistically significant. The most common reasons given for discontinuing a contraceptive method, regardless of which method was in use, were the desire to conceive, patient preference, no longer needing contraception, and vasectomy. Among the medical reasons, menorrhagia and intermenstrual bleeding were the reasons for discontinuing use of the method in 1.5 and 1.1 times per 100 women-years among DMPA users and in 1.8 and 4.7 times per 100 women-years among OC users. pelvic pain and infection were reasons for discontinuing contraceptive method, respectively, 4.4 and 4.3 times per 100 women-years among IUD users. In conclusion, the present study confirms, in this New Zealand population, the high discontinuation rate of contraceptive methods reported elsewhere. In contrast with previous suggestions, in this study, irregular bleeding was not an important medical reason for discontinuation of DMPA use. CONTRACEPTION 1999;59:227-231 (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:227 / 231
页数:5
相关论文
共 17 条
[1]
[Anonymous], CONTRACEPTION
[2]
Injectable contraceptive discontinuation and subsequent unintended pregnancy among low-income women [J].
Davidson, AR ;
Kalmuss, D ;
Cushman, LF ;
Romero, D ;
Heartwell, S ;
Rulin, M .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1997, 87 (09) :1532-1534
[3]
DEPO-PROVERA USE IN AN AUSTRALIAN METROPOLITAN PRACTICE [J].
FRASER, IS ;
DENNERSTEIN, GJ .
MEDICAL JOURNAL OF AUSTRALIA, 1994, 160 (09) :553-556
[4]
VAGINAL BLEEDING DISTURBANCES ASSOCIATED WITH THE DISCONTINUATION OF LONG-ACTING INJECTABLE CONTRACEPTIVES [J].
GRAY, RH ;
PARKER, RA ;
DIETHELM, P .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1981, 88 (03) :317-321
[5]
HIGGINS JE, 1986, J BIOSOC SCI, V18, P379
[6]
LIGGINS G, 1994, CONTRACEPTION, V50, P431
[7]
Menstrual bleeding patterns in Chinese women using the norplant subdermal implant [J].
Meng, F ;
Gu, SJ .
HUMAN REPRODUCTION, 1996, 11 :14-19
[8]
A COMPARATIVE-STUDY OF ONE-YEAR WEIGHT-GAIN AMONG USERS OF MEDROXYPROGESTERONE ACETATE, LEVONORGESTREL IMPLANTS, AND ORAL-CONTRACEPTIVES [J].
MOORE, LL ;
VALUCK, R ;
MCDOUGALL, C ;
FINK, W .
CONTRACEPTION, 1995, 52 (04) :215-219
[9]
*NZ CONTR HLTH STU, 1986, NZ MED J, V99, P283
[10]
Depot medroxyprogesterone acetate - Patterns of use and reasons for discontinuation [J].
Paul, C ;
Skegg, DCG ;
Williams, S .
CONTRACEPTION, 1997, 56 (04) :209-214